PRODUCTS
SERVICES
The investment objective of the scheme is to seek to generate long term capital appreciation throughinvesting in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
2.39
1 yrs 1 m
0.5%
439.02 Crs
0.50% on or before 30D, Nil after 30D
Large Growth
7.05
SIP 100 & Lumpsum 100
NA
Shibani Kurian,Abhishek Bisen,Dhananjay Tikariha
Investors understand that their principal will be at very high risk